North Castle Partners accepts offer from Nature’s Way to buy Enzymatic Therapy

GREENWICH, Conn. North Castle Partners on Wednesday announced that it has reached a definitive agreement to sell Enzymatic Therapy to Nature’s Way, a subsidiary of the Schwabe Pharmaceutical group.

Terms of the transaction, which is subject to government approval, were not disclosed.

The transaction was advised by Lincoln International, a leading mid-market investment bank, who acted as the exclusive financial advisor to Schwabe and Nature’s Way, working directly with the board of directors and senior management teams of both companies.  Morrison Cohen LLP served as legal counsel to Enzymatic Therapy and North Castle Partners.